Specifically, HDAC inhibitors improved the effectiveness of both chemotherapeutic drugs and immune checkpoint inhibitors in breast cancer treatment by inducing M1 polarization of TAMs (81, 184). The gene discussed is HDAC9; the disease is breast carcinoma.